Diverse synthetic approaches towards C1′-branched acyclic nucleoside phosphonates

Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, t...

Full description

Saved in:
Bibliographic Details
Published inOrganic & biomolecular chemistry Vol. 19; no. 32; pp. 6958 - 6963
Main Authors Kal ic, Filip, Dra ínský, Martin, Janeba, Zlatko
Format Journal Article
LanguageEnglish
Published CAMBRIDGE Royal Soc Chemistry 28.08.2021
Royal Society of Chemistry
Subjects
Online AccessGet full text
ISSN1477-0520
1477-0539
1477-0539
DOI10.1039/d1ob00751c

Cover

Loading…
Abstract Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1′-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1′ position. These intermediates can be further vastly diversified into target C1′-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1′-branched ANPs is emphasized by their analogy with C1′-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity ( e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research. Five diverse synthetic methods leading to 6-chloropurine ANPs branched at C1′ position were developed/optimized. These key intermediates can be used for the synthesis of a library of C1′-branched ANPs for evaluation of their biological properties.
AbstractList Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1'-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1' position. These intermediates can be further vastly diversified into target C1'-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1'-branched ANPs is emphasized by their analogy with C1'-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity (e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research.Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1'-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1' position. These intermediates can be further vastly diversified into target C1'-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1'-branched ANPs is emphasized by their analogy with C1'-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity (e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research.
Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1′-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1′ position. These intermediates can be further vastly diversified into target C1′-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1′-branched ANPs is emphasized by their analogy with C1′-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity ( e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research.
Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1 '-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1 ' position. These intermediates can be further vastly diversified into target C1 '-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1 '-branched ANPs is emphasized by their analogy with C1 '-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity (e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research.
Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to have diverse synthetic routes leading towards these molecules. In the past, many structural modifications were explored, but surprisingly, the field of C1′-branched ANPs has been neglected with only a handful of articles reporting their synthesis. Herein we describe and compare five convenient approaches leading to key synthetic 6-chloropurine ANPs bearing the 9-phosphonomethoxyethyl (PME) moiety branched at the C1′ position. These intermediates can be further vastly diversified into target C1′-branched ANPs bearing either natural or unnatural nucleobases. The importance of C1′-branched ANPs is emphasized by their analogy with C1′-substituted cyclic nucleotides (such as remdesivir, a broad-spectrum antiviral agent) and evaluation of their biological activity ( e.g. antiviral, antineoplastic, and antiprotozoal) will be a tempting subject of further research. Five diverse synthetic methods leading to 6-chloropurine ANPs branched at C1′ position were developed/optimized. These key intermediates can be used for the synthesis of a library of C1′-branched ANPs for evaluation of their biological properties.
Author Janeba, Zlatko
Dra ínský, Martin
Kal ic, Filip
AuthorAffiliation Charles University
Faculty of Science
Department of Organic Chemistry
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
AuthorAffiliation_xml – name: Department of Organic Chemistry
– name: Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
– name: Faculty of Science
– name: Charles University
Author_xml – sequence: 1
  givenname: Filip
  surname: Kal ic
  fullname: Kal ic, Filip
– sequence: 2
  givenname: Martin
  surname: Dra ínský
  fullname: Dra ínský, Martin
– sequence: 3
  givenname: Zlatko
  surname: Janeba
  fullname: Janeba, Zlatko
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34032256$$D View this record in MEDLINE/PubMed
BookMark eNqNks-KFDEQxoOsuLujF-9KgxdRWitJp9M5aq__YGEP6rlJ0tVMlp5kTNIuc_OZfCSfxOiMIywePBRVhN_3Uamqc3Lig0dCHlJ4QYGrlyMNBkAKau-QM9pIWYPg6uRYMzgl5yldA1Al2-YeOeUNcMZEe0Y-XrivGBNWaefzGrOzld5uY9B2janK4UbHMVU9_fHte22i9uV5rLTd2bmQfrEzhuRGrLbrkEp4nTHdJ3cnPSd8cMgr8vntm0_9-_ry6t2H_tVlbTmXudadVqCEslSMYqJGATeSMUul7mirqaTcgLSsoSOCQdBT21mGk5BsYoobviJP976l3y8LpjxsXLI4z9pjWNLARPlk05Uo6JNb6HVYoi_dFapljIMoI1mRxwdqMRsch210Gx13w59xFeD5HrhBE6ZkHXqLRwwAWsGlbFSpgBa6-3-6d1lnF3wfFp-L9NleamNIKeJ0lFEYfi19uKBXr38vvS8w3ILtwSxH7eZ_Sx7tJTHZo_XfO-I_AXZStYg
CitedBy_id crossref_primary_10_1002_cmdc_202300211
crossref_primary_10_1016_j_bioorg_2025_108240
crossref_primary_10_1016_j_ejmech_2024_116412
Cites_doi 10.1038/nature17180
10.2147/DDDT.S261154
10.1080/15257770500268673
10.1021/cr5002035
10.1021/acs.jmedchem.6b01594
10.1135/cccc19961525
10.3851/IMP2012
10.1021/acscentsci.0c00489
10.1016/j.antiviral.2006.06.002
10.1128/CMR.00162-20
10.1016/S0040-4020(00)00422-1
10.1002/med.21283
10.1016/j.antiviral.2015.11.009
10.1016/j.antiviral.2020.104899
10.3390/molecules25184307
10.1021/jm0102755
10.1038/323464a0
10.1016/j.tetlet.2011.10.037
10.1038/nrd1877
10.1021/acs.orglett.6b00869
10.1039/c2ra20842c
10.1007/s40265-017-0754-9
10.2165/00003495-200363150-00006
10.1080/15257770500265315
10.1038/srep43395
10.2174/1381612033453668
10.1002/med.21296
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2021
Copyright_xml – notice: Copyright Royal Society of Chemistry 2021
DBID AAYXX
CITATION
17B
1KM
BLEPL
DTL
EGQ
HGBXW
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7T7
7TM
8FD
C1K
FR3
P64
7X8
DOI 10.1039/d1ob00751c
DatabaseName CrossRef
Web of Knowledge
Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science Primary (SCIE, SSCI & AHCI)
Web of Science - Science Citation Index Expanded - 2021
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Biotechnology Research Abstracts
Technology Research Database
Nucleic Acids Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
Web of Science
Biotechnology Research Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1477-0539
EndPage 6963
ExternalDocumentID 34032256
000653774900001
10_1039_D1OB00751C
d1ob00751c
Genre Journal Article
GrantInformation_xml – fundername: Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences
  grantid: RVO 61388963
– fundername: Ministry of Education, Youth and Sports (MSMT in Czech) in the program INTER-EXCELLENCE
  grantid: LTAUSA18086
GroupedDBID -
0-7
0R
123
1TJ
29N
4.4
70
705
70J
7~J
AAEMU
AAGNR
AAIWI
AANOJ
AAXPP
ABASK
ABDVN
ABFLS
ABGFH
ABRYZ
ACGFS
ACIWK
ACLDK
ACNCT
ACPRK
ADMRA
ADSRN
AENEX
AFRAH
AFVBQ
AGKEF
AGRSR
AGSTE
AGSWI
ALMA_UNASSIGNED_HOLDINGS
ANUXI
ASKNT
AUDPV
BLAPV
BSQNT
C6K
CKLOX
CS3
D0L
DU5
DZ
EBS
ECGLT
EE0
EF-
F5P
GNO
HZ
H~N
IDZ
J3I
JG
KC5
M4U
N9A
O9-
OK1
P2P
R7B
R7C
RCNCU
RNS
RPMJG
RRA
RRC
RSCEA
SKA
SKF
SLH
TN5
TWZ
UCJ
VH6
VQA
WH7
X
YNT
YZZ
---
-DZ
-~X
0R~
70~
AAJAE
AAMEH
AAWGC
AAXHV
AAYXX
ABEMK
ABJNI
ABPDG
ABXOH
AEFDR
AENGV
AESAV
AETIL
AFLYV
AFOGI
AFRDS
AFRZK
AGEGJ
AHGCF
AKMSF
ALUYA
APEMP
CITATION
GGIMP
H13
HZ~
R56
RAOCF
XSW
17B
1KM
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
GROUPED_WOS_WEB_OF_SCIENCE
-JG
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7T7
7TM
8FD
C1K
FR3
P64
7X8
ID FETCH-LOGICAL-c337t-a8a90959c15d5f1b903b722c17a816a1713b07c241de0be0af68c2ef572f293b3
ISICitedReferencesCount 4
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000653774900001
ISSN 1477-0520
1477-0539
IngestDate Fri Jul 11 05:15:41 EDT 2025
Mon Jun 30 12:02:10 EDT 2025
Wed Feb 19 02:09:10 EST 2025
Fri Aug 29 16:01:58 EDT 2025
Fri May 30 07:59:27 EDT 2025
Tue Jul 01 01:52:12 EDT 2025
Thu Apr 24 23:09:51 EDT 2025
Sun Apr 17 04:30:16 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 32
Keywords MEDICINAL CHEMISTRY
NUCLEOTIDE ANALOGS
REMDESIVIR
VIRUS
PRODRUG
GS-5734
EBOLA
DERIVATIVES
INHIBIT
TENOFOVIR ALAFENAMIDE
Language English
LinkModel OpenURL
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c337t-a8a90959c15d5f1b903b722c17a816a1713b07c241de0be0af68c2ef572f293b3
Notes 10.1039/d1ob00751c
Electronic supplementary information (ESI) available: General experimental information, standard procedures, spectral data, characterization and copies of spectra of prepared compounds. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4391-8319
0000-0002-4495-0070
0000-0003-4654-679X
PMID 34032256
PQID 2562230540
PQPubID 2047497
PageCount 6
ParticipantIDs webofscience_primary_000653774900001
webofscience_primary_000653774900001CitationCount
rsc_primary_d1ob00751c
proquest_journals_2562230540
crossref_citationtrail_10_1039_D1OB00751C
crossref_primary_10_1039_D1OB00751C
proquest_miscellaneous_2532248224
pubmed_primary_34032256
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-08-28
PublicationDateYYYYMMDD 2021-08-28
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-28
  day: 28
PublicationDecade 2020
PublicationPlace CAMBRIDGE
PublicationPlace_xml – name: CAMBRIDGE
– name: England
– name: Cambridge
PublicationTitle Organic & biomolecular chemistry
PublicationTitleAbbrev ORG BIOMOL CHEM
PublicationTitleAlternate Org Biomol Chem
PublicationYear 2021
Publisher Royal Soc Chemistry
Royal Society of Chemistry
Publisher_xml – name: Royal Soc Chemistry
– name: Royal Society of Chemistry
References Charles (D1OB00751C/cit28) 1979; 94
De Clercq (D1OB00751C/cit1) 1986; 323
Chapman (D1OB00751C/cit9) 2003; 63
Warren (D1OB00751C/cit17) 2016; 531
Sun (D1OB00751C/cit22) 2016; 18
Wu (D1OB00751C/cit23b) 2005; 24
Holy (D1OB00751C/cit2) 2003; 9
Kundarapu (D1OB00751C/cit24) 2011; 52
Holý (D1OB00751C/cit3) 2006; 71
Ray (D1OB00751C/cit11) 2016; 125
Lo (D1OB00751C/cit16) 2017; 7
Hashemian (D1OB00751C/cit19) 2020; 14
De Clercq (D1OB00751C/cit5) 2013; 33
Baszczyňski (D1OB00751C/cit12) 2013; 33
Hocek (D1OB00751C/cit27) 1996; 61
Scott (D1OB00751C/cit10) 2017; 77
Siegel (D1OB00751C/cit14) 2017; 60
Cappellacci (D1OB00751C/cit13) 2002; 45
Jeffery (D1OB00751C/cit21) 2000; 56
Dejmek (D1OB00751C/cit25) 2012; 2
Slusarczyk (D1OB00751C/cit8) 2018; 26
Frydrych (D1OB00751C/cit26) 2020; 25
Eastman (D1OB00751C/cit18) 2020; 6
Wu (D1OB00751C/cit23a) 2005; 24
De Clercq (D1OB00751C/cit4) 2005; 4
Pertusat (D1OB00751C/cit6) 2012; 22
Konkolova (D1OB00751C/cit15) 2020; 182
Pradere (D1OB00751C/cit7) 2014; 114
Malin (D1OB00751C/cit20) 2020; 34
Jeffery, AL (WOS:000088199900003) 2000; 56
Konkolova, E (WOS:000576074300009) 2020; 182
Baszczynski, O (WOS:000325158000004) 2013; 33
Wu, MW (WOS:000234060900011) 2005; 24
Pradere, U (WOS:000342328500009) 2014; 114
DECLERCQ, E (WOS:A1986E225700061) 1986; 323
Sun, HL (WOS:000375891700080) 2016; 18
Lo, MK (WOS:000395416000001) 2017; 7
Pertusati (000653774900001.8) 2018; 26
Malin, JJ (WOS:000582927000003) 2021; 34
Holy, A (WOS:000240381200022) 2006; 71
MCKENNA, CE (WOS:A1979HM70100007) 1979
Hashemian, SM (WOS:000557425200001) 2020; 14
Holy, A (WOS:000186697900003) 2003; 9
Chapman, TM (WOS:000184678900006) 2003; 63
De Clercq, E (WOS:000325158000003) 2013; 33
Siegel, D (WOS:000396296100004) 2017; 60
Wu, MW (WOS:000234060900012) 2005; 24
Hocek, M (WOS:A1996VV80200011) 1996; 61
Warren, TK (WOS:000372064300055) 2016; 531
De Clercq, E (WOS:000233304600019) 2005; 4
Frydrych, J (WOS:000580384500001) 2020; 25
Eastman, RT (WOS:000537740300013) 2020; 6
Scott, LJ (WOS:000401714300007) 2017; 77
Cappellacci, L (WOS:000174506200005) 2002; 45
Dejmek, M (WOS:000306669300038) 2012; 2
Pertusati, Fabrizio (BCI:BCI201200571166) 2012; 22
Kundarapu, M (WOS:000297777600012) 2011; 52
Ray, AS (WOS:000369203900010) 2016; 125
References_xml – issn: 2018
  issue: 26
  publication-title: Phosphoramidates and phosphonamidates (ProTides) with antiviral activity
  doi: Slusarczyk Serpi Pertusati
– volume: 531
  start-page: 381
  year: 2016
  ident: D1OB00751C/cit17
  publication-title: Nature
  doi: 10.1038/nature17180
– volume: 14
  start-page: 3215
  year: 2020
  ident: D1OB00751C/cit19
  publication-title: Drug Des., Dev. Ther.
  doi: 10.2147/DDDT.S261154
– volume: 24
  start-page: 1543
  issue: 10–12
  year: 2005
  ident: D1OB00751C/cit23a
  publication-title: Nucleosides, Nucleotides Nucleic Acids
  doi: 10.1080/15257770500268673
– volume: 114
  start-page: 9154
  year: 2014
  ident: D1OB00751C/cit7
  publication-title: Chem. Rev.
  doi: 10.1021/cr5002035
– volume: 60
  start-page: 1648
  year: 2017
  ident: D1OB00751C/cit14
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.6b01594
– volume: 61
  start-page: 1525
  year: 1996
  ident: D1OB00751C/cit27
  publication-title: Collect. Czech. Chem. Commun.
  doi: 10.1135/cccc19961525
– volume: 22
  start-page: 181
  year: 2012
  ident: D1OB00751C/cit6
  publication-title: Antivir. Chem. Chemother.
  doi: 10.3851/IMP2012
– volume: 6
  start-page: 672
  issue: 5
  year: 2020
  ident: D1OB00751C/cit18
  publication-title: ACS Cent. Sci.
  doi: 10.1021/acscentsci.0c00489
– volume: 71
  start-page: 248
  year: 2006
  ident: D1OB00751C/cit3
  publication-title: Antiviral Res.
  doi: 10.1016/j.antiviral.2006.06.002
– volume: 34
  start-page: 1
  year: 2020
  ident: D1OB00751C/cit20
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.00162-20
– volume: 56
  start-page: 5077
  year: 2000
  ident: D1OB00751C/cit21
  publication-title: Tetrahedron
  doi: 10.1016/S0040-4020(00)00422-1
– volume: 33
  start-page: 1278
  year: 2013
  ident: D1OB00751C/cit5
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.21283
– volume: 125
  start-page: 63
  year: 2016
  ident: D1OB00751C/cit11
  publication-title: Antiviral Res.
  doi: 10.1016/j.antiviral.2015.11.009
– volume: 182
  start-page: 104899
  year: 2020
  ident: D1OB00751C/cit15
  publication-title: Antiviral Res.
  doi: 10.1016/j.antiviral.2020.104899
– volume: 25
  start-page: 4307
  year: 2020
  ident: D1OB00751C/cit26
  publication-title: Molecules
  doi: 10.3390/molecules25184307
– volume: 45
  start-page: 1196
  year: 2002
  ident: D1OB00751C/cit13
  publication-title: J. Med. Chem.
  doi: 10.1021/jm0102755
– volume: 323
  start-page: 464
  year: 1986
  ident: D1OB00751C/cit1
  publication-title: Nature
  doi: 10.1038/323464a0
– volume: 52
  start-page: 6896
  year: 2011
  ident: D1OB00751C/cit24
  publication-title: Tetrahedron Lett.
  doi: 10.1016/j.tetlet.2011.10.037
– volume: 4
  start-page: 928
  year: 2005
  ident: D1OB00751C/cit4
  publication-title: Nat. Rev. Drug Discovery
  doi: 10.1038/nrd1877
– volume: 94
  start-page: 739
  year: 1979
  ident: D1OB00751C/cit28
  publication-title: J. Chem. Soc., Chem. Commun.
– volume: 26
  volume-title: Phosphoramidates and phosphonamidates (ProTides) with antiviral activity
  year: 2018
  ident: D1OB00751C/cit8
– volume: 18
  start-page: 2260
  year: 2016
  ident: D1OB00751C/cit22
  publication-title: Org. Lett.
  doi: 10.1021/acs.orglett.6b00869
– volume: 2
  start-page: 6970
  year: 2012
  ident: D1OB00751C/cit25
  publication-title: RSC Adv.
  doi: 10.1039/c2ra20842c
– volume: 77
  start-page: 1017
  year: 2017
  ident: D1OB00751C/cit10
  publication-title: Drugs
  doi: 10.1007/s40265-017-0754-9
– volume: 63
  start-page: 1597
  year: 2003
  ident: D1OB00751C/cit9
  publication-title: Drugs
  doi: 10.2165/00003495-200363150-00006
– volume: 24
  start-page: 1569
  year: 2005
  ident: D1OB00751C/cit23b
  publication-title: Nucleosides, Nucleotides Nucleic Acids
  doi: 10.1080/15257770500265315
– volume: 7
  start-page: 43395
  year: 2017
  ident: D1OB00751C/cit16
  publication-title: Sci. Rep.
  doi: 10.1038/srep43395
– volume: 9
  start-page: 2567
  year: 2003
  ident: D1OB00751C/cit2
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/1381612033453668
– volume: 33
  start-page: 1304
  year: 2013
  ident: D1OB00751C/cit12
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.21296
– volume: 25
  start-page: ARTN 4307
  year: 2020
  ident: WOS:000580384500001
  article-title: Efficient Synthesis of α-Branched Purine-Based Acyclic Nucleosides: Scopes and Limitations of the Method
  publication-title: MOLECULES
  doi: 10.3390/molecules25184307
– volume: 114
  start-page: 9154
  year: 2014
  ident: WOS:000342328500009
  article-title: Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
  publication-title: CHEMICAL REVIEWS
  doi: 10.1021/cr5002035
– volume: 26
  year: 2018
  ident: 000653774900001.8
  publication-title: Phosphoramidates and phosphonamidates (ProTides) with antiviral activity
– start-page: 739
  year: 1979
  ident: WOS:A1979HM70100007
  article-title: FUNCTIONAL SELECTIVITY IN PHOSPHONATE ESTER DEALKYLATION WITH BROMOTRIMETHYLSILANE
  publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS
– volume: 24
  start-page: 1569
  year: 2005
  ident: WOS:000234060900012
  article-title: Synthesis of 9-[1-(substituted)-2-(phosphonomethoxy)ethyl]adenine derivatives as possible antiviral agents
  publication-title: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
  doi: 10.1080/15257770500265315
– volume: 24
  start-page: 1543
  year: 2005
  ident: WOS:000234060900011
  article-title: Synthesis of 9-[1-(substituted)-3-(phosphonomethoxy)propyl]adenine derivatives as possible antiviral agents
  publication-title: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
  doi: 10.1080/15257770500268673
– volume: 7
  start-page: ARTN 43395
  year: 2017
  ident: WOS:000395416000001
  article-title: GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
  publication-title: SCIENTIFIC REPORTS
  doi: 10.1038/srep43395
– volume: 45
  start-page: 1196
  year: 2002
  ident: WOS:000174506200005
  article-title: Ribose-modified nucleosides as ligands for adenosine receptors:: Synthesis, conformational analysis, and biological evaluation of 1′-C-methyl adenosine analogues
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm0102755
– volume: 56
  start-page: 5077
  year: 2000
  ident: WOS:000088199900003
  article-title: Synthesis of acyclic nucleoside and nucleotide analogues from amino acids: A convenient approach to a PMEA-PMPA hybrid
  publication-title: TETRAHEDRON
– volume: 34
  start-page: ARTN e00162-20
  year: 2021
  ident: WOS:000582927000003
  article-title: Remdesivir against COVID-19 and Other Viral Diseases
  publication-title: CLINICAL MICROBIOLOGY REVIEWS
  doi: 10.1128/CMR.00162-20
– volume: 125
  start-page: 63
  year: 2016
  ident: WOS:000369203900010
  article-title: Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
  publication-title: ANTIVIRAL RESEARCH
  doi: 10.1016/j.antiviral.2015.11.009
– volume: 33
  start-page: 1304
  year: 2013
  ident: WOS:000325158000004
  article-title: Medicinal Chemistry of Fluorinated Cyclic and Acyclic Nucleoside Phosphonates
  publication-title: MEDICINAL RESEARCH REVIEWS
  doi: 10.1002/med.21296
– volume: 71
  start-page: 248
  year: 2006
  ident: WOS:000240381200022
  article-title: Antiviral acyclic nucleoside phosphonates structure activity studies
  publication-title: ANTIVIRAL RESEARCH
  doi: 10.1016/j.antiviral.2006.06.002
– volume: 61
  start-page: 1525
  year: 1996
  ident: WOS:A1996VV80200011
  article-title: Synthesis and antiviral activity of acyclic nucleotide analogues derived from 6-(aminomethyl)purines and purine-6-carboxamidines
  publication-title: COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS
– volume: 9
  start-page: 2567
  year: 2003
  ident: WOS:000186697900003
  article-title: Phosphonomethoxyalkyl analogs of nucleotides
  publication-title: CURRENT PHARMACEUTICAL DESIGN
– volume: 77
  start-page: 1017
  year: 2017
  ident: WOS:000401714300007
  article-title: Tenofovir Alafenamide: A Review in Chronic Hepatitis B
  publication-title: DRUGS
  doi: 10.1007/s40265-017-0754-9
– volume: 6
  start-page: 672
  year: 2020
  ident: WOS:000537740300013
  article-title: Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
  publication-title: ACS CENTRAL SCIENCE
  doi: 10.1021/acscentsci.0c00489
– volume: 323
  start-page: 464
  year: 1986
  ident: WOS:A1986E225700061
  article-title: A NOVEL SELECTIVE BROAD-SPECTRUM ANTI-DNA VIRUS AGENT
  publication-title: NATURE
– volume: 14
  start-page: 3215
  year: 2020
  ident: WOS:000557425200001
  article-title: A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
  publication-title: DRUG DESIGN DEVELOPMENT AND THERAPY
  doi: 10.2147/DDDT.S261154
– volume: 33
  start-page: 1278
  year: 2013
  ident: WOS:000325158000003
  article-title: The Acyclic Nucleoside Phosphonates (ANPs): Antonin Holy's Legacy
  publication-title: MEDICINAL RESEARCH REVIEWS
  doi: 10.1002/med.21283
– volume: 531
  start-page: 381
  year: 2016
  ident: WOS:000372064300055
  article-title: Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
  publication-title: NATURE
  doi: 10.1038/nature17180
– volume: 2
  start-page: 6970
  year: 2012
  ident: WOS:000306669300038
  article-title: One-pot build-up procedure for the synthesis of variously substituted purine derivatives
  publication-title: RSC ADVANCES
  doi: 10.1039/c2ra20842c
– volume: 22
  start-page: 181
  year: 2012
  ident: BCI:BCI201200571166
  article-title: Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy
  publication-title: Antiviral Chemistry & Chemotherapy
  doi: 10.3851/IMP2012
– volume: 4
  start-page: 928
  year: 2005
  ident: WOS:000233304600019
  article-title: Acyclic nucleoside phosphonates: A key class of antiviral drugs
  publication-title: NATURE REVIEWS DRUG DISCOVERY
  doi: 10.1038/nrd1877
– volume: 60
  start-page: 1648
  year: 2017
  ident: WOS:000396296100004
  article-title: Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/acs.jmedchem.6b01594
– volume: 182
  start-page: ARTN 104899
  year: 2020
  ident: WOS:000576074300009
  article-title: Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses
  publication-title: ANTIVIRAL RESEARCH
  doi: 10.1016/j.antiviral.2020.104899
– volume: 18
  start-page: 2260
  year: 2016
  ident: WOS:000375891700080
  article-title: Asymmetric Hydrogenation of α-Purine Nucleobase-Substituted Acrylates with Rhodium Diphosphine Complexes: Access to Tenofovir Analogues
  publication-title: ORGANIC LETTERS
  doi: 10.1021/acs.orglett.6b00869
– volume: 52
  start-page: 6896
  year: 2011
  ident: WOS:000297777600012
  article-title: Synthesis of new acyclic nucleoside phosphonates (ANPs) substituted on the 1′ and/or 2′ positions
  publication-title: TETRAHEDRON LETTERS
  doi: 10.1016/j.tetlet.2011.10.037
– volume: 63
  start-page: 1597
  year: 2003
  ident: WOS:000184678900006
  article-title: Tenofovir disoproxil fumarate
  publication-title: DRUGS
SSID ssj0019764
Score 2.3671558
Snippet Acyclic nucleoside phosphonates (ANPs) represent a significant class of antiviral, anticancer, and antiprotozoal compounds. It is therefore highly desirable to...
Source Web of Science
SourceID proquest
pubmed
webofscience
crossref
rsc
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6958
SubjectTerms Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Antiviral Agents - chemical synthesis
Antiviral Agents - chemistry
Antiviral Agents - pharmacology
Bases (nucleic acids)
Biological activity
Chemistry
Chemistry, Organic
Cyclic nucleotides
Intermediates
Molecular Structure
Nucleosides
Nucleosides - chemical synthesis
Nucleosides - chemistry
Nucleosides - pharmacology
Nucleotides
Organophosphonates - chemical synthesis
Organophosphonates - chemistry
Organophosphonates - pharmacology
Phosphonates
Physical Sciences
Science & Technology
Title Diverse synthetic approaches towards C1′-branched acyclic nucleoside phosphonates
URI http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000653774900001
https://www.ncbi.nlm.nih.gov/pubmed/34032256
https://www.proquest.com/docview/2562230540
https://www.proquest.com/docview/2532248224
Volume 19
WOS 000653774900001
WOSCitedRecordID wos000653774900001
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaW7QEuiFdpoKAgekGrQGxn8zh2s60K4nFgK1VcFtuJValVUu1mD3DiN_GT-CXMOI4T1EUqXFaR492sPF_Gn-2Zbwg5KDQtVKp1MKWKBZFQPBBhyQKmpNQ6ylQq8ET3w8f45DR6dzY9G42-DqKWNo18rb5vzSv5H6tCG9gVs2T_wbLuR6EBrsG-8AkWhs8b2XhugipKlB0AHmekV61EuBFuwIDY9SSnNqBhxgKJZTTOgWMK9U2hvHWFcsY1luycXJ3XawxUR_I5pKxttqYyGMFk_a6e7kR1teKc00YBD1Mx_Rh3aRxHXomJOY-fV-sLvJjNbZZQJ_ttcv2rUhoi--VSNBf1cDeCme1VNnSgUZIEGFvTzi_Dtla0yHndbIAuu8XZ-tA4a8Xc7XwcZ60HvObrQ45SqQWtJfIeqvoZzcUZ9jdvkR0GCwk2JjuHR4u3791JE9AxE3nQ_e9OwpZnb_pv_0larq1EgJes1mordTE0ZXGP3LXrC_-wBct9MiqrB-R23pnqIflsQeM70Pg9aHwLGj-nv378dHDxLVz8Hi7-EC6PyOnx0SI_CWxljUBxnjSBSEWGG8CKTouppjILuYTBUTQRKY0FTSiXYaKA3RVlKMtQ6DhVrNTThGngh5LvknFVV-Ue8YusQNE0IQQvUehS6ELxVCZKhzJUKfPIq27olsrKzmP1k8ulCX_g2XJOP83MMOceeen6XrViK1t77XcWWNqXcb0E5g5EF9cfHnnhbsPQ4vkXILjeYB-YvSIMm_bI49Zy7jE8CnFqiz2yC6Z0zT0EPHIwtK7rYUg8h0VUZg7KPEJv0i23I4HCE82Tvz3zKbnTv2P7ZNysNuUz4MCNfG5h_BvnXrEy
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diverse+synthetic+approaches+towards+C1%E2%80%B2-branched+acyclic+nucleoside+phosphonates&rft.jtitle=Organic+%26+biomolecular+chemistry&rft.au=Kal+ic%2C+Filip&rft.au=Dra+%C3%ADnsk%C3%BD%2C+Martin&rft.au=Janeba%2C+Zlatko&rft.date=2021-08-28&rft.issn=1477-0520&rft.eissn=1477-0539&rft.volume=19&rft.issue=32&rft.spage=6958&rft.epage=6963&rft_id=info:doi/10.1039%2Fd1ob00751c&rft.externalDocID=d1ob00751c
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0520&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0520&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0520&client=summon